{
    "eid": "2-s2.0-85164232909",
    "title": "A new era of the Asian clinical research network: a report from the ATLAS international symposium",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "clinical trial",
        "genomic medicine",
        "international cooperation",
        "phase I clinical trial"
    ],
    "authors": [
        "Mitsumi Terada",
        "Kenichi Nakamura",
        "Tomohiro Matsuda",
        "Hitomi Sumiyoshi Okuma",
        "Kazuki Sudo",
        "Akhmal Yusof",
        "Marcelo Imasa",
        "Ekaphop Sirachainan",
        "Pham Tuan Anh",
        "Yasuhiro Fujiwara",
        "Noboru Yamamoto",
        "Pei Jye Voon",
        "Kulkanya Chokephaibulkit",
        "Tatsuhiro Shibata",
        "Manami Inoue",
        "Hiroyuki Mano",
        "Tatsunori Shimoi",
        "Virote Sriuranpong",
        "Kan Yonemori",
        "Kazuaki Shimada"
    ],
    "citedby-count": 0,
    "ref-count": 32,
    "ref-list": [
        "Differential globalization of industry- and non-industry-sponsored clinical trials",
        "Regulatory changes after the enforcement of the new clinical trials act in Japan",
        "Current status and open issues concerning global clinical trials (GCTs) in Japan and East Asia",
        "Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial",
        "Regulatory and operational challenges in conducting Asian international academic trial for expanding the indications of cancer drugs",
        "MASTER KEY project: powering clinical development for rare cancers through a platform trial",
        "Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer",
        "Phase I trials as valid therapeutic options for patients with cancer",
        "Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-experiences and perspectives of the Asian oncology early phase 1 consortium",
        "Malaysia\u2019s clinical research ecosystem",
        "Genomic spectra of biliary tract cancer",
        "Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma",
        "Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma",
        "Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence",
        "International strategy in cancer epidemiology: Japan\u2019s involvement in global projects and future role",
        "Establishment and implementation of cancer genomic medicine in Japan",
        "The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: standard operating procedures based on empirical analyses",
        "Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Tokyo",
            "@id": "60018424",
            "affilname": "National Cancer Center Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018424",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kuching",
            "@id": "60090650",
            "affilname": "Hospital Umum Sarawak",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60026825",
            "affilname": "Pharmaceuticals and Medical Devices Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026825",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Chuo-ku",
            "@id": "60023890",
            "affilname": "National Cancer Center Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023890",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tokyo",
            "@id": "60022755",
            "affilname": "National Cancer Center Japan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022755",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "129936519",
            "affilname": "Thai Society of Clinical Oncology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/129936519",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hanoi",
            "@id": "117938902",
            "affilname": "Vietnam National Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117938902",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "115217419",
            "affilname": "Clinical Research Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/115217419",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Manila",
            "@id": "101752285",
            "affilname": "St. Luke\u2019s Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101752285",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "Clinical Research Malaysia",
        "PMDA",
        "Thai Society of Clinical Oncology",
        "NIH",
        "AMED",
        "NCC"
    ]
}